- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Avita Medical Ltd (RCEL)
Avita Medical Ltd stock price live, this page displays NASDAQ RCEL stock exchange data. View the RCEL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Avita Medical Ltd real time stock price chart below.
What Is the Avita Medical Ltd Stock Price Today?
The Avita Medical Ltd stock price today is 5.70.
What Is the Stock Symbol for Avita Medical Ltd?
The stock symbol for Avita Medical Ltd is ""RCEL.""
What Stock Exchange Does Avita Medical Ltd Trade On?
Avita Medical Ltd is listed and trades on the NASDAQ stock exchange.
Is Avita Medical Ltd a Good Stock to Buy?
Determining whether Avita Medical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RCEL quote. (ISIN: US05380C1027)
What Is the Avita Medical Ltd Stock Price Today?
The Avita Medical Ltd stock price today is 5.70.
What Is the Stock Symbol for Avita Medical Ltd?
The stock symbol for Avita Medical Ltd is ""RCEL.""
What Stock Exchange Does Avita Medical Ltd Trade On?
Avita Medical Ltd is listed and trades on the NASDAQ stock exchange.
Is Avita Medical Ltd a Good Stock to Buy?
Determining whether Avita Medical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RCEL quote. (ISIN: US05380C1027)
5.70
-0.24(-4.04%)
Closed·
After Hours
5.66-0.04(-0.70%)
·
Fair Value
An estimate of a Avita Medical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.61
5.97
52 wk Range
4.71
14.16
RCEL Scorecard
Full Analysis
3 analysts have revised their earnings upwards for the upcoming period
RCEL is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Avita Medical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.615.97
52 wk Range
4.7114.16
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RCEL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Avita Medical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
17.08
Upside
+199.66%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Avita Medical Ltd Company Profile
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company markets, sells, and distributes PermeaDerm, a biosynthetic wound matrix; and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Avita Medical Ltd SWOT Analysis
Regenerative Pionee | AVITA Medical, a leader in regenerative medicine, faces growth challenges despite a strong product pipeline and recent regulatory approvals |
Financial Crossroads | Q4 sales miss and delayed profitability projections raise concerns, yet FY2025 guidance suggests 55-65% revenue growth potential |
Market Expansion | Explore AVITA's strategic move into Australia and New Zealand, potentially serving as a blueprint for future international growth |
Analyst Perspectives | Price targets range from $12 to $21, with AVITA trading below its intrinsic value. Next earnings report on February 20, 2025, could be a catalyst |
Avita Medical Ltd Earnings Call Summary for Q1/2025
- Q1 2025 results: Net loss of $0.53/share, revenue $18.5M, missing estimates; stock plunged 17.79% to $7.67 in after-hours trading
- Revenue up 67% YoY despite miss; company maintains FY guidance of $100-106M, projecting 55-65% growth
- Avita aims for GAAP profitability by Q4 2025 and free cash flow generation in H2 2025; expects material revenue from Co Helix by Q3
- CEO highlights transition to multi-product platform; CFO confident in cash balance to achieve plans despite market reaction
- Risks include market volatility, declining gross margins, execution challenges for new products, and macroeconomic uncertainties
Last Updated: 08/05/2025, 22:36
Read Full TranscriptCompare RCEL to Peers and Sector
Metrics to compare | RCEL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRCELPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | −0.6x | −0.5x | |
PEG Ratio | 0.11 | 0.02 | 0.00 | |
Price/Book | −33.1x | 2.3x | 2.6x | |
Price / LTM Sales | 2.1x | 8.3x | 3.1x | |
Upside (Analyst Target) | 236.1% | 106.6% | 46.1% | |
Fair Value Upside | Unlock | 16.4% | 6.9% | Unlock |
Analyst Ratings
3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 17.08
(+199.66% Upside)
Earnings
Latest Release
May 08, 2025
EPS / Forecast
-0.53 / -0.32
Revenue / Forecast
18.50M / 20.75M
People Also Watch
FAQ
What Stock Exchange Does Avita Medical Trade On?
Avita Medical is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Avita Medical?
The stock symbol for Avita Medical is "RCEL."
What Is the Avita Medical Market Cap?
As of today, Avita Medical market cap is 151.38M.
What Is Avita Medical's Earnings Per Share (TTM)?
The Avita Medical EPS (TTM) is -2.19.
When Is the Next Avita Medical Earnings Date?
Avita Medical will release its next earnings report on 06 Aug 2025.
From a Technical Analysis Perspective, Is RCEL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Avita Medical Stock Split?
Avita Medical has split 1 times.
How Many Employees Does Avita Medical Have?
Avita Medical has 260 employees.
What is the current trading status of Avita Medical (RCEL)?
As of 12 Jul 2025, Avita Medical (RCEL) is trading at a price of 5.70, with a previous close of 5.94. The stock has fluctuated within a day range of 5.61 to 5.97, while its 52-week range spans from 4.71 to 14.16.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.